Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Wohlkönig Christoph |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien. [Poster]
Web of Science

 

Terbuch, A; Absenger, G; Steinlechner, S; Jost, P; Wurm, R; Wohlkonig, C; Olschewski, H; Richtig, E; Koch, L; Winder, T; Woll, E; Gerger, A Autriche - AUsTrian Registry for Immune CHEckpoint inhibitors
ONCOL RES TREAT. 2021; 44: 229-229. [Poster]
Web of Science

 

Terbuch, A; Absenger, G; Steinlechner, S; Mayer, M; Jost, P; Wurm, R; Wohlkönig, C; John, N; Olschewski, H; Richtig, E; Koch, L; Winder, T; Wöll, E; Gerger, A; AUTRICHE – AUsTrian Registry for Immune CHEckpoint inhibitors
Jahrestagung der DGHO; OKT 1-4, 2021; Berlin. 2021. [Poster]

 

Pfeiffer, S; Polachova, J; Wohlkoenig, C; Olschewski, H Immunotherapy against Biomarkers
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):756-756. [Poster]
Web of Science

 

Troester N, Palfner M, Wohlkoenig C, Trinker M, Dominco M, Avian A ServeHF in real life
International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels . 2016; -ERS International Congress; SEP 3-7, 2016; London, UK. [Poster]

 

Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Bertsch, A; Olschewski, A; Olschewski, H; Hrzenjak, A Histone deacetylase inhibitor panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma via HIF-1α destabilisation
Wiener Klinische Wochenschrift. 2015; 127: 816-817.-Annual Meeting of the Austrian Society of Pneumology; Oct 15-17, 2015; Graz, Austria. [Poster]
Web of Science

 

Fischer, C; Leithner K; Wohlkoenig, C; Quehenberger, F; Bertsch A; Olschewski O, Olschewski, A; Hrzenjak, A Reduction of hypoxia-induced cisplatin resistance of NSCLC cells via HIF-1alpha destabilization
Forschungsfeld Krebsforschung Mitgliederversammlung; SEPT 22, 2014; Graz, AUSTRIA. 2014. [Oral Communication]

 

Hrzenjak, A; Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Olschewski, A; Olschewski, H Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization
European Journal of Cancer. 2014; 50 Supplement 5: S203-S203.-23rd Biennial Congress of the European Association for Cancer Research; JULY 5-8, 2014; Munich, Germany. [Poster]

 

Hrzenjak, A; Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Olschewski, A; Olschewski, H Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization.
EUR J CANCER. 2014; 50: S203-S204. Doi: 10.1016/S0959-8049(14)50741-1 [Poster]
Web of Science FullText FullText_MUG

 

Leithner, K; Hrzenjak, A; Trötzmüller, M; Moustafa, T; Köfeler, HC; Wohlkoenig, C; Stacher, E; Harris, AL; Olschewski, A; Olschewski, H Role of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase in lung cancer
European Journal of Cancer . 2014; 50 Supplement 5: S84-S84.-23rd Biennial Congress of the European Association for Cancer Research; JULY 5-8, 2014; Munich, Germany. [Poster]

 

Leithner, K; Hrzenjak, A; Trotzmuller, M; Moustafa, T; Kofeler, HC; Wohlkoenig, C; Stacher, E; Harris, AL; Olschewski, A; Olschewski, H; Role of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase in lung cancer.
EUR J CANCER. 2014; 50: S84-S84.-EACR 23; Doi: 10.1016/S0959-8049(14)50315-2 [Poster]
Web of Science FullText FullText_MUG

 

Leithner, K; Hrzenjak, A; Trötzmüller, M; Moustafa, T; Köfeler, HC; Wohlkoenig, C; Stacher, E; Lindenmann, J; Harris, AL; Olschewski, A; Olschewski, H The gluconeogenic enzyme PCK2 mediates an adaptive response to glucose depletion in lung cancer
Abstract book. 2014; (X6):2015--Keystone Symposium Tumor Metabolism; March 16-21, 2014; Whistler, CANADA. [Poster]

 

Wohlkonig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H; Cytosporone B, an nr4a1 specific cytotoxic agent, is not prone to hypoxia-induced apoptosis resistance in A549 cells.
WIEN KLIN WOCHENSCHR. 2013; 125(19-20):663-663.-ÖGP; OKT 24-26, 2013; Vienna, AUSTRIA. [Poster]
Web of Science

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Hofmann, A; Ebner, B; et al Expression of membrane metallo-endopeptidase (CD10) in lung cancer - regulation by hypoxia and prognostic significance
Abstract CD of the Cell Symposium Angiogenesis, Metabolic Regulation, and Cancer Biology. 2012; P1.48--Cell Symposium - Angiogenesis, Metabolic Regulation and Cancer Biology; July 6-8, 2012; Leuven, Belgium. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Hofmann, NA; Ebner, B; Quehenberger, F; Smolle-Jüttner, F-M; Philipsen, S; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma
European Respiratory Journal . 2012; 40 Suppl. 56: P4167--22nd Annual Congress ofthe European Respiratory Society; SEPT 1-5, 2012; Vienna. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Ebner, B; Guelly, C; Smolle-Jüttner, FM; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Neprilysin is induced by hypoxia and is a prognostic factor in non-small cell lung cancer
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A24-A24.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie; SEPT 8-10, 2011; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Hofmann, NA; Ebner, B; Guelly, C; Smolle-Jüttner, F-M; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression profiling identifies neprilysin as a hypoxia-regulated prognostic factor in non-small cell lung cancer
Doctoral Day; NOV 4, 2011; Graz, AUSTRIA. 2011. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Jüttner, F.-M.; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature
European Respiratory Journal Supplement. 2011; P1964--European Respiratory Society Annual Congress; SEPT 24-28, 2011; Amsterdam, The Netherlands. [Poster]

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Down-regulation of the pro-apoptotic BCL-2 family member protein Bax by hypoxia may contribute to hypoxia-induced chemotherapy resistance in A549 lung cancer cells
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A33-A33.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie; SEPT 8-10, 2011; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Wohlkonig, C; Meilinger, M; Flick, H; Fritz, W; Hesse, C; Wurm, R; Polachova, J; Krause, R; Popper, H; Olschewski, H Necrotizing epithelioid granulomatous infiltrates - mycobacterium infection, what else?
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A11-A11. [Poster]
Web of Science

 

Frille, A; Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H. The influence of erythropoietin on proliferation in lung cancer cell lines
Wiener Klinische Wochenschrift2010; 122(21-2):A51--Jahrestagung 2010 der Österreichischen Gesellschaft für Pneumologie; OKT 7-9, 2010; Graz, AUSTRIA. [Poster]
Web of Science

 

Leithner, K; Wohlkoenig, C; Katschnig, AM; Stacher, E; Lindenmann, J; Smolle-Jüttner, F-M; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression of key enzymes for gluconeogenesis and glycogen deposition in lung cancer
Abstract book, 2010; P17--Joint ZMF and Doctoral Days; NOV 4-6, 2010; Graz, AUSTRIA. [Poster]

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Nagaraj, C; Stacher, E; Balint, Z; Olschewski, A; Olschewski, H Expression of TASK-1 and TASK-3 channels in non-small cell lung cancer
EJC SUPPL. 2010; 8(5): 576 Doi: 10.1016/S1359-6349(10)71377-X [Poster]
Web of Science FullText FullText_MUG

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Nagaraj, C; Stacher, E; Bálint, Z; Olschewski, A; Olschewski, H Expression of TASK-1 and TASK-3 channels in non-small cell lung cancer
Magazine of European Medical Oncology, 2010; 3 Suppl 2: P22--PneumoUpdate; JUN 17-19; Innsbruck, AUSTRIA. [Oral Communication]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Juttner, F; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Constitutive expression of carbonic anhydrase IX in hypoxic and normoxic non-small cell lung cancer fragments
EJC SUPPL. 2010; 8(5): 192 Doi: 10.1016/S1359-6349(10)70999-X [Poster]
Web of Science FullText FullText_MUG

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Juttner, FM; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression of key enzymes for gluconeogenesis and glycogen deposition in lung cancer
WIEN KLIN WOCHENSCHR. 2010; 122(21-22): A50-A50. [Poster]
Web of Science

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Jüttner, F-M; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression of carbonic anhydrase IX splice variants in a novel ex vivo lung cancer model for hypoxic adaptation
Abstract book, 2010; V19--Joint ZMF and Doctoral Days; NOV 4-6, 2010; Graz, AUSTRIA. [Oral Communication]

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Autocrine vascular endothelial growth factor signaling has no influence on the apoptosis induction by cisplatin in non-small cell lung cancer cell lines
EJC SUPPL. 2010; 8(5): 538 Doi: 10.1016/S1359-6349(10)71339-2 [Poster]
Web of Science FullText FullText_MUG

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Interfering with autocrine vascular endothelial growth factor signalling does not reverse hypoxia-induced cisplatin resistance in non-small cell lung cancer cell lines.
Magazine of European Medical Oncology. 2010; 3 Suppl 02/10: -P18--Pneumoupdate; JUN 17-19; Innsbruck, AUSTRIA. [Poster]

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Blocking autocrine secreted vascular endothelial growth factor does not enhance cisplatin-induced apoptosis in non-small cell lung cancer cell lines
Wiener Klinische Wochenschrift 2010; 122(21-2):A53--Jahrestagung 2010 der Österreichischen Gesellschaft für Pneumologie; OKT 7-9, 2010; Graz. [Oral Communication]
Web of Science

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Nagaraj, C; Stacher, E; Bálint, Z; Lindenmann, J; Hrzenjak, A; Popper, HH; Olschewski, A; Olschewski, H Expression of TASK-1 and TASK-3 channels in non-small cell lung cancer
Abstract Book. 2009; P44--Joint ZMF and Doctoral Days; NOV 5-6; Graz, Austria. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Moderate hypoxia induces hypoxic adaptation in an ex-vivo non-small cell lung cancer model
Wiener Klinische Wochenschrift 2009; 121(17-1):A50--ÖGP Annual Congress; JUN 11-13; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H A novel ex-vivo model for the evaluation of hypoxic adaptation in non-small cell lung cancer using surgery explants
European Respiratory Journal.2009; 34(S53):30s--Annual Conference of the European Respiratory Society; SEPT 12-16, 2009; Vienna, AUSTRIA. [Poster]

 

Wohlkoenig, C; Leithner, K;Li, Y;Tang, B;Hrzenjak, A;Olschewski, A;Olschewski, H Blocking vascular endothelial growth factor does not reverse hypoxia-induced cisplatin resistance in A549 non-small cell lung cancer cells
Abstract Book, V162009; -Joint ZMF and Doctoral Days; NOV 5-6, 2009; Graz, AUSTRIA. [Oral Communication]

 

Wohlkoenig, C;Leithner, K;Stacher, E;Lindenmann, J;Popper, HH;Hrzenjak, A;Olschewski, A;Olschewski, H An ex-vivo tumor fragment model to study the effects of hypoxia on non-small cell lung cancer (NSCLC).
Abstract Book, P452009; -Joint ZMF and Doctoral Days; NOV 5-6, 2009; Graz, AUSTRIA. [Poster]

 

Hof, A; Wohlkönig C, Leithner K, Gabor S, Stacher E, Olschewski H, Olschewski A Endothelin-1 confers to hypoxic signalling in primary human pulmonary arterial smooth muscle cell proliferation
MEMO2008; 1/2008(S3):40-40.-PneumoUpdate 2008; 19.-21.06.2008; Innsbruck, AUSTRIA. (ISBN: 1865-5041 ) [Poster]

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Nagaraj, C; Olschewski, A; Olschewski, H TASK-1 current sets the membrane potential in non-small cell lung cancer (NSCLC) cells and is responsible for hypoxic depolarization
American Journal of Respiratory and Critical Care Medicine2008; 177: A463--International Conference of the American Thoracic Society ; MAY 16-21, 2008; Toronto, Canada. [Poster]

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Nagaraj, C; Olschewski, A; Olschewski, H Two-pore domain K+ channel TASK-1 maintains the membrane potential in non-small cell lung cancer cells.
European Respiratory Journal 2008; 32(S52):825s-825s.-Annual Congress of the European Respiratory Society; OCT 4-8, 2008; Berlin, GERMANY. [Poster]

 

Wohlkoenig, C; Leithner, K; Li, Y; Tang, B; Olschewski, A; Olschewski, H Hypoxia induces apoptosis resistance to cisplatin without involvement of selection pressure in A549 cells.
American Journal of Respiratory and Critical Care Medicine2008; 177: A562--International Conference of the American Thoracic Society; MAY 16-21, 2008; Toronto, Canada. [Oral Communication]

 

Wohlkoenig, C; Leithner, K; Li, Y; Tang, B; Stacher, E; Olschewski, A; Olschewski, H Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line
European Respiratory Journal 2008; 32(S52):458s--Annual Congress of the European Respiratory Society; OCT 4-8, 2008; Berlin, GERMANY. [Poster]

 

Wohlkönig, C; Leithner K, Li Y, Tang B, Nagaraj C, Olschewski A, Olschewski H Two-pore domain K+ channel TASK-1 maintains the membrane potential in non-small-cell lung cancer (NSCLC) cells
MEMO, Magazine of European Medical Oncology2008; 1/2008(S3):38-39.-PneumoUpdate 2008; 19.-21.06.2008; Innsbruck, AUSTRIA. (ISBN: 1865-5041 ) [Poster]

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Olschewski, A; Olschewski, H Hypoxia induces apoptosis resistance to cisplatin without involvement of selection pressure in NSCLC cell lines.
ZMF Day; NOV 21, 2007; Graz, AUSTRIA. 2007. [Oral Communication]

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Olschewski, A; Olschewski, H Hypoxia induces apoptosis resistance to cisplatin without involvement of selection pressure in A549 lung cancer cells
Ist International Allergooncology Symposium, Vienna; APR 16, 2007; Vienna, AUSTRIA. 2007. [Poster]

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Olschewski, A; Olschewski, H Hypoxia causes apoptosis resistance to cisplatin in A549 lung cancer cells without prior cell-death induction
Pneumo Update 2007; JUN 8-9, 2007; Innsbruck, AUSTRIA. 2007. [Poster]

 

Wohlkoenig, C; Leithner, K; Li, Y; Tang, B; Nagaraj, C; Olschewski, A; Olschewski, H TASK-1 may play a role in the mechanisms of hypoxia-induced cisplatin resistance in A549 cells
ZMF Day ; NOV 21, 2007; Graz, Austria. 2007. [Poster]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum